Simplex Trading
SLN

Simplex Trading’s Silence Therapeutics SLN Stock Holding History

Simplex Trading’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.23K Sell
612
-3,379
-85% -$18.6K ﹤0.01% 8144
2025
Q4 		$24.3K Buy
3,991
+3,340
+513% +$21.4K ﹤0.01% 6300
2025
Q3 		$3K Sell
651
-16
-2% -$89 ﹤0.01% 8555
2025
Q2 		$3K Buy
667
+416
+166% +$1.78K ﹤0.01% 8025
2025
Q1 		$0 Buy
251
+200
+392% +$977 ﹤0.01% 9579
2024
Q4 		$0 Buy
+51
New +$658 ﹤0.01% 9539

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Simplex Trading's SLN Position: Q1 2026 in Review

Simplex Trading reduced its Silence Therapeutics (SLN) stake by 85% in Q1 2026, selling an estimated $18.6K and leaving 612 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #8144.

Simplex Trading first reported a position in SLN in Q4 2024 and has held it in 6 quarters since. The position peaked at $24.3K in Q4 2025. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Simplex Trading held 612 shares of Silence Therapeutics worth $3.23K as of Q1 2026.
  • Simplex Trading sold 3,379 Silence Therapeutics shares in Q1 2026, an estimated $18.6K.
  • Silence Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8144 holding.
  • Simplex Trading first reported a position in Silence Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Simplex Trading's Silence Therapeutics position peaked at $24.3K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.